v3.26.1
Segment and Geographic Information (Tables)
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Reconciliation of Segment Revenue, Measures of Segments Profit or Loss, and Significant Segment Expenses from Continuing Operations Reconciled to Consolidated Loss Before Income Taxes

The following tables reflect the reconciliation of segment revenue and significant segment expenses from continuing operations reconciled to the consolidated income (loss) from continuing operations before income taxes and equity method investments:

 

For the Three Months Ended June 30, 2026

 

 

Cannabis

 

 

Segment Totals

 

 

Other

 

 

Corporate (3)

 

 

Total

 

Sales to external customers

$

53,523

 

 

$

53,523

 

 

$

10,454

 

 

 

-

 

 

$

63,977

 

Cost of sales

 

(26,246

)

 

 

(26,246

)

 

 

(7,758

)

 

 

-

 

 

 

(34,004

)

Selling, general and administrative expenses

 

(15,203

)

 

 

(15,203

)

 

 

(712

)

 

 

(2,896

)

 

 

(18,811

)

Segment operating income (loss)

$

12,074

 

 

$

12,074

 

 

$

1,984

 

 

$

(2,896

)

 

$

11,162

 

Reconciliation of segment operating income (loss) to income from continuing operations before taxes and income from equity method investments(1)

 

Other expense, net (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

(707

)

Income from continuing operations before taxes and equity method investments

 

 

 

 

 

 

 

 

 

 

 

 

$

10,455

 

 

 

For the Three Months Ended June 30, 2025

 

 

Cannabis

 

 

Segment Totals

 

 

Other

 

 

Corporate (3)

 

 

Total

 

Sales to external customers

$

50,842

 

 

$

50,842

 

 

$

9,057

 

 

 

-

 

 

$

59,899

 

Cost of sales

 

(29,502

)

 

 

(29,502

)

 

 

(8,055

)

 

 

-

 

 

 

(37,557

)

Selling, general and administrative expenses

 

(11,606

)

 

 

(11,606

)

 

 

(843

)

 

 

(2,962

)

 

 

(15,411

)

Segment operating income (loss)

$

9,734

 

 

$

9,734

 

 

$

159

 

 

$

(2,962

)

 

$

6,931

 

Reconciliation of segment operating income (loss) to loss from continuing operations before taxes and income from equity method investments(1)

 

Other income, net (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

5,517

 

Income from continuing operations before taxes and equity method investments

 

 

 

 

 

 

 

 

 

 

 

 

$

12,448

 

 

 

For the Six Months Ended June 30, 2026

 

 

Cannabis

 

 

Segment Totals

 

 

Other

 

 

Corporate (3)

 

 

Total

 

Sales to external customers

$

103,267

 

 

$

103,267

 

 

$

10,948

 

 

$

 

 

$

114,215

 

Cost of sales

 

(54,682

)

 

 

(54,682

)

 

 

(8,574

)

 

 

 

 

 

(63,256

)

Selling, general and administrative expenses

 

(30,023

)

 

 

(30,023

)

 

 

(1,224

)

 

 

(3,506

)

 

 

(34,753

)

Segment operating income (loss)

$

18,562

 

 

$

18,562

 

 

$

1,150

 

 

$

(3,506

)

 

$

16,206

 

Reconciliation of segment operating income to income from continuing operations before taxes and income from equity method investments(1)

 

Other expense, net (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,353

)

Income from continuing operations before taxes and equity method investments

 

 

 

 

 

 

 

 

 

 

 

 

$

14,853

 

 

 

For the Six Months Ended June 30, 2025

 

 

Cannabis

 

 

Segment Totals

 

 

Other

 

 

Corporate (3)

 

 

Total

 

Sales to external customers

$

90,069

 

 

$

90,069

 

 

$

9,510

 

 

$

 

 

$

99,579

 

Cost of sales

 

(53,460

)

 

 

(53,460

)

 

 

(9,597

)

 

 

 

 

 

(63,057

)

Selling, general and administrative expenses

 

(23,342

)

 

 

(23,342

)

 

 

(1,586

)

 

 

(5,102

)

 

 

(30,030

)

Segment operating income (loss)

$

13,267

 

 

$

13,267

 

 

$

(1,673

)

 

$

(5,102

)

 

$

6,492

 

Reconciliation of segment operating income to loss from continuing operations before taxes and income from equity method investments(1)

 

Other income, net (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

4,827

 

Income from continuing operations before taxes and equity method investments

 

 

 

 

 

 

 

 

 

 

 

 

$

11,319

 

(1)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.
(2)
Other income (expense), net is comprised of interest expense, interest income, foreign exchange (loss) gain, other income (expense).
(3)
Other corporate expenses are comprised of expenses related to centralized corporate functions such as accounting, treasury, information technology, legal, human services, and internal audit expenses.
Summary of Interest Income, Interest Expense, Depreciation and Amortization, Other Significant Non-Cash Items and Expenditures for Capital Assets by Reportable Segment

The following tables summarize our interest income, interest expense, depreciation and amortization, other significant noncash items, and expenditures for capital assets by reportable segment:

 

For the Six Months Ended June 30, 2026

 

 

Cannabis

 

Segment Totals

 

Other

 

Corporate

 

Consolidated Totals

 

Interest income

$

414

 

$

414

 

$

149

 

$

388

 

$

951

 

Interest expense

$

468

 

$

468

 

$

532

 

$

-

 

$

1,000

 

Depreciation and amortization

$

6,985

 

$

6,985

 

$

1,560

 

$

37

 

$

8,582

 

Share based compensation

$

134

 

$

134

 

$

-

 

$

535

 

$

669

 

Other significant noncash items:

 

 

 

 

 

 

 

 

 

 

Non-cash lease expense

$

377

 

$

377

 

$

114

 

$

-

 

$

491

 

Expenditures for segment assets

$

14,215

 

$

14,215

 

$

1,247

 

$

-

 

$

15,462

 

 

 

For the Six Months Ended June 30, 2025

 

 

Cannabis

 

Segment Totals

 

Other

 

Corporate

 

Consolidated Totals

 

Interest income

$

134

 

$

134

 

$

1

 

$

49

 

$

184

 

Interest expense

$

592

 

$

592

 

$

924

 

$

-

 

$

1,516

 

Depreciation and amortization

$

6,055

 

$

6,055

 

$

2,273

 

$

82

 

$

8,410

 

Share based compensation

$

85

 

$

85

 

$

19

 

$

164

 

$

268

 

Other significant noncash items:

 

 

 

 

 

 

 

 

 

 

Non-cash lease expense

$

534

 

$

534

 

$

85

 

$

-

 

$

619

 

Expenditures for segment assets

$

4,581

 

$

4,581

 

$

708

 

$

-

 

$

5,289

 

Summary of Total Assets by Reportable Segment

The following tables summarize our total assets by reportable segment:

 

 

June 30, 2026

 

 

December 31, 2025

 

Assets

 

 

 

 

 

 

Cannabis

 

$

346,323

 

 

$

335,428

 

Total assets for reportable segment

 

$

346,323

 

 

$

335,428

 

Other

 

 

46,915

 

 

 

49,038

 

Corporate

 

 

35,229

 

 

 

38,630

 

Consolidated total assets from continuing operations

 

$

428,467

 

 

$

423,096

 

Summary of Assets by Geographic Location

The Company’s primary operations are in the United States, Canada, and the Netherlands. The following tables summarize our assets by geographic location:

Total assets from continuing operations

 

June 30, 2026

 

 

December 31, 2025

 

United States

 

$

29,283

 

 

$

36,039

 

Canada

 

 

367,036

 

 

 

363,702

 

Netherlands

 

 

32,148

 

 

 

23,355

 

 

$

428,467

 

 

$

423,096

 

 

 

 

 

 

 

 

Long-lived assets from continuing operations

 

June 30, 2026

 

 

December 31, 2025

 

United States

 

$

27,300

 

 

$

28,970

 

Canada

 

 

212,223

 

 

 

218,582

 

Netherlands

 

 

28,618

 

 

 

21,107

 

 

$

268,141

 

 

$

268,659